Purple Biotech (Purple Biotech) Change In Payables And Accrued Expense : $0.26 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Purple Biotech Change In Payables And Accrued Expense?

Purple Biotech's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $1.10 Mil. It means Purple Biotech's Accounts Payable & Accrued Expense increased by $1.10 Mil from Sep. 2023 to Dec. 2023 .

Purple Biotech's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.26 Mil. It means Purple Biotech's Accounts Payable & Accrued Expense increased by $0.26 Mil from Dec. 2022 to Dec. 2023 .

Purple Biotech Change In Payables And Accrued Expense Historical Data

The historical data trend for Purple Biotech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Change In Payables And Accrued Expense Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.42

-2.93

1.03

2.93

0.26

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.90	-1.25	-0.85	1.26	1.10

Purple Biotech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26 Mil.

Purple Biotech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (Purple Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (NAS:PPBT) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

PPBT:Israel 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.